Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: BioNTech 0.114, AstraZeneca 15.288.
BioNTech vs AstraZeneca Net Worth and Market Cap
BioNTech (BNTX) and AstraZeneca (AZN) are peers in Vaccines. BioNTech reported revenue of $114M as of Q2 2026, compared with $15.3B for AstraZeneca. AstraZeneca leads on revenue.
BioNTech's gross margin is 8.1% versus 82.5% for AstraZeneca. BioNTech's net margin is -777.3% versus 20.1% for AstraZeneca.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, BioNTech, AstraZeneca.| Metric | BioNTech | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $114.00M | $15.29B |
| Cost of Revenue | $105.00M | $2.68B |
| Gross Profit | $9.00M | $12.61B |
| Operating Income | $-1.02B | $4.25B |
| Net Income | $-886.00M | $3.08B |
| R&D Expense | $595.00M | $3.49B |
| Earnings Per Share | -$3.5 | $1.97 |
| Gross Margin | 8.1% | 82.5% |
| Operating Margin | -897.8% | 27.8% |
| Net Profit Margin | -777.3% | 20.1% |
| Free Cash Flow | $-48.00M | $1.82B |
| Cumulative Free Cash Flow | $19.56B | $120.67B |
| Operating Cash Flow | $12.00M | $3.36B |
| Cash & Equivalents | $10.52B | $7.56B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.